129 related articles for article (PubMed ID: 6816244)
1. Studies of the mechanism of chloroquine binding to synthetic DOPA-melanin.
Stepień KB; Wilczok T
Biochem Pharmacol; 1982 Nov; 31(21):3359-65. PubMed ID: 6816244
[TBL] [Abstract][Full Text] [Related]
2. Binding characteristics of fluoroquinolones to synthetic levodopa melanin.
Ono C; Tanaka M
J Pharm Pharmacol; 2003 Aug; 55(8):1127-33. PubMed ID: 12956903
[TBL] [Abstract][Full Text] [Related]
3. Interaction of quinidine, disopyramide and metoprolol with melanin in vitro in relation to drug-induced ocular toxicity.
Buszman E; Rózańska R
Pharmazie; 2003 Jul; 58(7):507-11. PubMed ID: 12889538
[TBL] [Abstract][Full Text] [Related]
4. Interaction of neomycin, tobramycin and amikacin with melanin in vitro in relation to aminoglycosides-induced ototoxicity.
Buszman E; Wrześniok D; Trzcionka J
Pharmazie; 2007 Mar; 62(3):210-5. PubMed ID: 17416198
[TBL] [Abstract][Full Text] [Related]
5. Interaction of thioridazine with ocular melanin in vitro.
Buszman E; Rózańska R
Acta Pol Pharm; 2003; 60(4):257-61. PubMed ID: 14714852
[TBL] [Abstract][Full Text] [Related]
6. Interaction of chlorpromazine, fluphenazine and trifluoperazine with ocular and synthetic melanin in vitro.
Buszman E; Beberok A; Rózańska R; Orzechowska A
Pharmazie; 2008 May; 63(5):372-6. PubMed ID: 18557422
[TBL] [Abstract][Full Text] [Related]
7. Binding of aflatoxin B1 to melanin.
Larsson P; Larsson BS; Tjälve H
Food Chem Toxicol; 1988 Jul; 26(7):579-86. PubMed ID: 3141255
[TBL] [Abstract][Full Text] [Related]
8. Electron spin resonance studies of chloroquine-melanin complexes.
Buszman E; Kopera M; Wilczok T
Biochem Pharmacol; 1984 Jan; 33(1):7-11. PubMed ID: 6322795
[TBL] [Abstract][Full Text] [Related]
9. Spectroscopic studies of chemically modified synthetic melanins.
Wilczok T; Bilińska B; Buszman E; Kopera M
Arch Biochem Biophys; 1984 Jun; 231(2):257-62. PubMed ID: 6329095
[TBL] [Abstract][Full Text] [Related]
10. Interactions of flavins with melanin. Studies on equilibrium binding of riboflavin to dopa-melanin and some spectroscopic characteristics of flavin-melanin complex.
Kozik A; Korytowski W; Sarna T; Bloom AS
Biophys Chem; 1990 Oct; 38(1-2):39-48. PubMed ID: 2128193
[TBL] [Abstract][Full Text] [Related]
11. Affinity of drugs for dopa-auto-oxidation melanin and tyrosinase-catalyzed dopa-melanin in vitro.
Hayasaka S; Tsuchiya M; Noda S; Setogawa T; Mizuno K
Ophthalmic Res; 1988; 20(6):376-9. PubMed ID: 3148876
[TBL] [Abstract][Full Text] [Related]
12. Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicity.
Debing I; Ijzerman AP; Vauquelin G
Mol Pharmacol; 1988 Apr; 33(4):470-6. PubMed ID: 3357487
[TBL] [Abstract][Full Text] [Related]
13. Interpretation of Ocular Melanin Drug Binding Assays. Alternatives to the Model of Multiple Classes of Independent Sites.
Manzanares JA; Rimpelä AK; Urtti A
Mol Pharm; 2016 Apr; 13(4):1251-7. PubMed ID: 26820602
[TBL] [Abstract][Full Text] [Related]
14. Drug Distribution to Retinal Pigment Epithelium: Studies on Melanin Binding, Cellular Kinetics, and Single Photon Emission Computed Tomography/Computed Tomography Imaging.
Rimpelä AK; Schmitt M; Latonen S; Hagström M; Antopolsky M; Manzanares JA; Kidron H; Urtti A
Mol Pharm; 2016 Sep; 13(9):2977-86. PubMed ID: 26741026
[TBL] [Abstract][Full Text] [Related]
15. Physical factors affecting chloroquine binding to melanin.
Schroeder RL; Pendleton P; Gerber JP
Colloids Surf B Biointerfaces; 2015 Oct; 134():8-16. PubMed ID: 26141438
[TBL] [Abstract][Full Text] [Related]
16. Melanin counter act puromycin-induced inhibition of collagen and DNA biosynthesis in human skin fibroblasts.
Wrześniok D; Surazyński A; Karna E; Buszman E; Pałka J
Life Sci; 2005 Jun; 77(5):528-38. PubMed ID: 15904670
[TBL] [Abstract][Full Text] [Related]
17. Melanin affinity of N-(2-diethylaminoethyl)-4-iodobenzamide, an effective melanoma imaging agent.
Labarre P; Papon J; Moreau MF; Moins N; Bayle M; Veyre A; Madelmont JC
Melanoma Res; 2002 Apr; 12(2):115-21. PubMed ID: 11930107
[TBL] [Abstract][Full Text] [Related]
18. Investigation by NMR spectroscopy of the interaction between synthetic soluble (-)-dopa melanin and drugs.
Salazar-Bookaman MM; Fowble J; Weber P; Patil PN
Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):576-82. PubMed ID: 2515443
[TBL] [Abstract][Full Text] [Related]
19. Interaction of several mono- and dihydroxybenzene derivatives of various depigmenting potencies with L-3,4-dihydroxyphenylalanine-melanin.
Menter JM; Willis I
Arch Biochem Biophys; 1986 Feb; 244(2):846-56. PubMed ID: 3080956
[TBL] [Abstract][Full Text] [Related]
20. Mass Spectrometric and Spectrophotometric Analyses Reveal an Alternative Structure and a New Formation Mechanism for Melanin.
Li Y; Liu J; Wang Y; Chan HW; Wang L; Chan W
Anal Chem; 2015 Aug; 87(15):7958-63. PubMed ID: 26153916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
